Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: MRI to Measure Liver Fat Content [NA]

View source ↗

Summary

This clinical trial update notes completion of a study using MRI to measure liver fat content. Conditions include fatty liver disease and hepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Fatty Liver, Hepatitis | NA | Status: COMPLETED